US News2 years ago
House investigation says FDA approval process of Alzheimer’s drug was ‘rife with irregularities’ | CNN
[ad_1] CNN — A congressional investigation found that the US Food and Drug Administration’s “atypical collaboration” to approve a high-priced Alzheimer’s drug was “rife with irregularities.”...
